The original publication of this article did not include a current disclosures statement.Reference Stahl 1 This is included in full below, along with an additional acknowledgement.
Disclosures
Arbor Scientia reports financial support for manuscript preparation, writing, referencing, literature search, and copy editing from Axsome Therapeutics. Outside the submitted work, Dr. Stahl reports grants and personal fees from ACADIA, Alkermes, Arbor Pharmaceuticals, AstraZeneca, Avanir, Axovant, Biogen, Celgene, Dey, Eli Lilly, EnVivo, Forest, Forum, Intra-Cellular Therapies, Janssen, Jazz, Lundbeck, Merck, Servier, Shire, Sprout, Sunovion, Takeda, Teva, Tonix, and Vanda; grants from AssureX, Braeburn Pharmaceuticals, BristolMyerSquibb, CeNeRx, Cephalon, Glaxo Smith Kline, ISSWSH, JayMac, Mylan, Sepracor, TMS NeuroHealth Centers, Valeant, and Wyeth; personal fees from ADAMAS, Allergan, Axsome, Biomarin, Biopharma, ClearView, Concert, DepoMed, EMD Serono, Ferring, Genentech, Innovative Science Solutions, Neos, Novartis, Noveida, Orexigen, Otsuka, PamLabs, Perrigo, Pfizer, Pfizer Israel, Pierre Fabre, Reviva, Taisho, Taliaz, Trius, Vertex, and Viforpharma; personal fees from Genomind, where he is a board member; and board membership at RCT Logic.
Acknowledgments
The author thanks Arbor Scientia Medical Group, Carlsbad, CA, USA for providing medical writing support, which was funded by Axsome Therapeutics, New York, NY, USA.
